4DMedical FCF per Share
Free Cash Flow per Share of 4DMedical (4DX.AX) as of Oct 18, 2026.
Get this data via API
Financial Data API
FCF per Share
-0.00AUD
YoY
-93.22%
Last updated:
Free Cash Flow per Share of 4DMedical is 2026 -0.00 AUD. Free Cash Flow per Share of 4DMedical was 2025 -0.07 AUD. It decreases by -93.22% higher compared to the previous year.
The 4DMedical FCF per Share history
3 Years
10 Years
25 Years
Max
FCF per Share
Date
FCF per Share
Jan 1, 2019
-0.03 AUD
Jan 1, 2020
-0.03 AUD
Jan 1, 2021
-0.05 AUD
Jan 1, 2022
-0.09 AUD
Jan 1, 2023
-0.06 AUD
Jan 1, 2024
-0.05 AUD
Jan 1, 2025
-0.07 AUD
Jan 1, 2026
-0.00 AUD
| YEAR | FCF per Share | YoY |
|---|---|---|
| -0.00AUD | -93.22% | |
| -0.07AUD | +38.33% | |
| -0.05AUD | -19.89% | |
| -0.06AUD | -26.85% | |
| -0.09AUD | +66.19% | |
| -0.05AUD | +55.59% | |
| -0.03AUD | +24.72% | |
| -0.03AUD | -17.68% | |
| -0.03AUD | +49.66% | |
| -0.02AUD | +364.43% | |
| -0.00AUD | -99.83% | |
| -2.73AUD | -38.68% | |
| -4.45AUD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
4DMedical Stock analysis
What does 4DMedical do? 4DMedical Ltd, headquartered in Melbourne, Australia, operates in the Health Care sector, specializing in four-dimensional lung imaging technology. The company commercializes its patented XV Technology, enabling physicians to assess regional airflow and identify respiratory issues earlier through its FDA-cleared XV Lung Ventilation Analysis Software (XV LVA) and CT LVAS. These solutions, delivered via a SaaS model, utilize existing hospital imaging equipment or the company's XV Scanner, with commercial rollout initiated through partnerships like I-MED Radiology Network, serving approximately 250 clinics nationwide. 4DMedical is one of the most popular companies on Eulerpool.
Frequently Asked Questions about 4DMedical stock
On Eulerpool you can find the complete historical development of Free Cash Flow per Share 4DMedical since 2006 – with annual values, charts, and detailed analysis.
FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Cash Flow — 4DMedical
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — 4DMedical
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth